Epithelial membrane antigen (EMA), also known as MUC1, is a mucinous glycoprotein fixed to the luminal domain of the epithelial cell membrane of normal breast ducts. However, in breast cancer cells, it is usually dispersed in the cytoplasm. EMA staining patterns of 330 breast carcinomas were examined, and three groups formed: lineal (16%), cytoplasmic (75%), and negative (9%). Although these patterns were somewhat related to histological cancer types, this was not statistically significant. However, EMA showed statistically significant univariate relationships to tumor grade, tumor size, estrogen and progesterone receptors, and nodal stage. Logistic regression analysis showed that among these variables, all of which were univariately related to node metastasis, only tumor size and EMA were independent nodal stage predictors. A combined analysis of these two factors revealed that the statistical probability of a tumor metastasizing to four or more nodes increased in each tumor size group from 0.9% to 12% for pT1, from 2% to 29% for pT2 and from 10% to 63% for pT3, depending on the EMA staining. The tumors showing a lineal pattern were the least metastasizing, while the EMA-negative tumors were the most. After recognizing these relationships between EMA staining patterns and other well-known differentiation markers and the lymph node metastatic capacity of carcinomas, and considering the results obtained by others on survival, one might conclude that EMA is both a differentiation marker and a histological prognostic factor.
Introduction
Epithelial mucins may be gel-forming or membrane linked with anti-adhesive cell functions [16] . Epithelial membrane antigen (EMA) was the term coined by Heyderman [15] for the glycoproteic antigens recognized by an antibody directed against membranes from human milk fat globules. Included among the group of tissue specific antigens, EMA is expressed preferentially by breast carcinomas and is essentially synonymous to HMFG, MAM-6, episialin, polymorphous epithelial mucin, Ca 15.3, DF3 and others (more than twenty). These react with different epitopes of the same molecule, now called MUC1, which will probably be accepted as the definitive term [6, 7] . Coded by the MUC1 gene, it is produced in the rough endoplasmic reticulum, packaged in the Golgi apparatus, and carried to the luminal domain of the cell membrane, where it develops anti-adhesive and lubricant functions [17, 19, 29] . Its metabolism is regulated by steroid hormones, and its production increases during lactation [24, 32] . EMA is also upregulated in carcinogenesis, and its serum levels, when high, are indicators of poor prognosis for breast cancer patients [1, 12, 18, 25, 31] . The almost constant presence of EMA in breast cancer cells facilitates the detection of micrometastases in lymph nodes and bone marrow. Over the last fifteen years, attempts have been made to obtain additional benefits bodies for human estrogen (clone 1D5) and progesterone (clone 1A6) receptors and EMA (clone E29, 1:10) were used. Serial 3-4 µm thick sections from archival paraffin blocks were cut and mounted on DAKO ChemMate slides, dried by heating at 55ºC for 12 hours, dewaxed, rehydrated, and boiled in a pressure cooker in DAKO ChemMate Buffer for Retrieval for 2 minutes, followed by cooling to room temperature for 20 minutes. The staining protocol was made in a DAKO TechMate 500 immunostainer using the DAKO ChemMate HRP/DAB System kit and prediluted antibodies.
The cases were re-evaluated by two of us (S.L.M. and A.J.). For the histological grading of the tumors the Elston and Ellis modification of the Scarff-Bloom-Richardson method was applied [11] . Criteria for lymphatic vessel invasion, as described by Orbo et al., were also taken into account [26] . ER and PR were considered to be positive when 20% or more cells showed a positive immunoreaction. EMA was always positive, at least in a few cells of a tumor area. Stained sections were scored from 1 to 3 according to whether the number of cells stained was less than 20%, between 20% and 60% or 61% or more, respectively, with 1 being classified as negative, and 2 and 3 as positive. Only cells with a moderate to strong staining in character were counted; thus, intensity, when low, even though diffuse, was considered negative. Initially, eight patterns were distinguished: lineal tubular (24), lineal peripheral (12), lineal disordered (17), pure cytoplasmic (208), cytoplasmic mixed with internal (25) , external (8) or irregular lineal (7) and negative (29) . These patterns were then ordered into three groups: lineal (lineal 2 or 3 and cytoplasmic 1), cytoplasmic (cytoplasmic 2 or 3 and any kind of lineal), and negative (lineal or cytoplasmic 1). Lymph node staging followed the criteria of Nottingham [13] : node-negative (stage A), metastasis to 1-3 nodes (stage B), and metastasis to four or more nodes (stage C). Invasive micropapillary carcinomas were withdrawn from the analysis because of their high level of node dissemination (33.3% in node stage C) which obscured the positive influence of the lineal pattern of EMA in relation to metastasis. After the descriptive phase of the EMA staining, the univariate relations of the EMA with other carcinoma features were studied using the χ 2 test. Logistic regression analysis was then performed to detect actual prognostic factors. According to the final logistic regression model obtained, a range of probabilities was established with the factors selected. Data were processed using the SPSS/PC+ 9.0 computer program.
Results
EMA lineal staining in some breast carcinomas (n=53, 16%) outlined the luminal surfaces in well-formed tubules (Fig1), the external surface of papillary and micropapillary structures (Fig 2) , or was disordered lineal in defective tubules (Fig 3) . However, in most tumors diffuse EMA cytoplasmic staining was predominant or exclusive (n = 248, 75%), and the great majority of these were of the NOS type or lobular carcinomas. EMA negativity was seen in 29 cases (9%), 27 of which were NOS ductal and 2 medullary carcinomas. Table 2 presents the EMA staining patterns and tumor types in from the histological use of EMA. EMA-positive relationships have been found with WHO histological tumor grade [10] , estrogen receptors [2, 10, 14, 23] , lymph node metastases [24] , and survival [2, 4, 5, 9, 14, 23, 33, 34] , although there remains much controversy, explained by the diverse polyclonal and monoclonal antibodies used, the very different methods of evaluating the results, and the different number of cases studied. The aim of this study was to address this problem using 330 cases stained with E-29, which is a very suitable anti-human EMA monoclonal antibody for formalin-fixed, paraffin-embedded blocks [15] . Using this monoclonal antibody and a new method for evaluating the results, we obtained statistically significant data directly favoring the role of EMA as a differentiation marker and, indirectly, as a prognostic factor.
Materials and Methods
A total of 330 consecutive breast carcinomas treated between 1996 and 1999 by extirpation plus axillary dissection were studied. The general characteristics of the cases are shown in Table 1 . The specimens were buffered-formalin-fixed and paraffin-embedded. Histological sections were stained with H&E and immunostained for EMA, as well as for estrogen (ER) and progesterone (PR) receptors. DAKO-prediluted anti- Table 3 presents the univariate statistical analysis of the relationships of the lineal (MPCa excluded), cytoplasmic, and negative EMA groups with tumor size, tumor grade, ER, PR, and nodal stage of dissemination. It was also seen that the EMA groups were independently related to each of the three parameters used to carry out histological grading: tubule formation (p = 0.000), nuclear grade (p = 0.004), and mitotic grade (p = 0.01).
A more significant association was found between EMA and nodal metastasis when in the logistic regression test EMA, and those other variables related to EMA, i.e., tumor grade, tumor size, and hormone receptors, were analyzed regarding nodal stages A or B versus stage C ( Table 4 ). The p-value for EMA was 0.0087, in third place in order of significance following tumor size and tumor grade. Given that the independent variables in Table 4 were interrelated, it was necessary to recur to a logistic regression model to determine which of these variables were able to predict node metastasis. After using a forward stepwise (Wald) method of logistic regression, only tumor size and EMA entered into the equation, because tumor grade was eliminated after the selection of tumor size. Using this method, it was also possible to see that the EMA-cytoplasmic and 422 · S. Luna-Moré et al. Fig. 3 . Disordered EMA lineal deposits covering only one surface or discontinued opposite sides of distorted tubules of a NOS ductal carcinoma. EMA, ×100 -negative groups had a 10.7 and 14.5 times increased nodal stage C risk, respectively, over the EMA lineal type, while the equivalent relationship for pT2 and pT3 tumors regarding pT1 was 2.8 and 11.8 times higher, respectively. At the same time, with the data obtained from the logistic regression test, a combined analysis of tumor size and EMA for predicting the lymph node spread was specially useful (Table 5) . It was seen how the predictive capacity of tumor size in relation to node stage C varied in each tumor size group depending on the type of EMA staining. This statistical probability shifted from 0.9% to 12% for pT1, from 2% to 29% for pT2, and from 10% to 63% for the pT3 group, depending on whether EMA staining was lineal or negative.
Discussion
Within the process of neoplastic transformation of breast cancer cells, EMA may experience changes that have morphological expression. MUC1 gene alterations may affect signal peptides [30] , and in this case, EMA cannot be transported to their correct place. The best differentiated type of carcinoma, the tubular type, shows an EMA picture completely similar to normal. Notable alterations seen in otherwise well-differentiated carcinomas are the reversed polarization in papillary and micropapillary carcinomas and the disordered EMA lineal pattern in colloid and the best differentiated NOS carcinomas. MUC1 gene alteration might manifest in EMA cytoplasmic dispersion and in its absence or low positivity, which were related to lobular, medullary, and NOS ductal carcinomas in this report. Although some relationships exist between the type of carcinoma and the EMA picture, a greater number of special ductal carcinoma types will be necessary to achieve a statistically significant result. To our knowledge, nobody has demonstrated this link, although isolated connections between EMA pattern and cancer type have been recognized for tubular [34] and lobular carcinomas [3, 8] . EMA histology was useful for statistical purposes after establishing three groups (lineal 16%, cytoplasmic 75% and negative 9%). It is interesting to note that similar proportions of EMA staining patterns can be deduced from the descriptions of some reports [3, 23] , in which other monoclonal antibodies were used. This means that the controversial results might be attributed primarily to the method of quantification and evaluation of the staining patterns of EMA rather than to the antibodies used. It also has to be borne in mind that although describing the same pictures, some authors frequently put lineal and cytoplasmic groups together, evaluating only the percentage and the intensity of the staining, but not the pattern, and even using different cut-off points in the percentage of positivity [3, 4, 9, 10, 14, 23, 27, 33, 34, 35] . For the statistical analysis in our study, cases of invasive micropapillary carcinoma were eliminated, because they were highly metastasizing [20, 21, 22] unlike the rest of the EMA lineal group. In our analysis, a very close relationship was found between EMA and tumor grade (p = 0.000), a relationship mentioned previously by Ellis in one of his reports on this issue [10] . The correlation we observed between EMA and tumor grade was also found with each of the grading factors, tubule formation, nuclear grade, and mitotic grade, all three markers of tumor differentiation. The conservation of hormone receptors by cancer cells is another important expression of tumor differentiation, and a relationship between EMA and ER has been found by some [2, 10, 14, 23] , but not by others [3, 4, 9, 35] . In this work, a statistically significant relationship was seen not only between EMA and ER (p=0.031), but also between EMA and PR (p = 0.035), a finding that has not been reported previously.
It has to be emphasized that tumors with the lineal pattern have a better survival [5, 14, 34] and that EMAnegative cases have a poor survival [2, 34] . We are unable to comment on survival because of the very short follow-up of our cases, but we did find a correlation between EMA and a metastatic potential of breast cancer cells to the axillary lymph nodes, a feature previously reported exclusively by MacGuckin et al. [23] . With the exception of MPCa cases (33.3% in nodal stage C), in the lineal EMA group of tumors, 56% were in nodal stage A, 42.9% in stage B, and 2.3% in stage C. In the cytoplasmic and EMA-negative groups, 20% and 27.6% of the cases, respectively, were in nodal stage C. Tumor size, tumor grade, ER, PR and EMA were independent variables univariately related to nodal stage C, but logistic regression analysis selected only tumor size and EMA. Hence, EMA could be used to improve the predictive capacity of tumor size on nodal metastasis. Combined analysis of both factors showed that the nodal stage C statistical risk for a breast cancer shifted from 0.9% to 12% for pT1, from 2% to 29% for pT2 and from 10% to 63% for pT3, depending on the EMA pattern. The EMA lineal pattern was the least node metastasizing, and the negative pattern was the most, with the aforementioned exception of micropapillary carcinomas in the lineal group. Anyway, given the number of cases in these groups, EMA staining may help in improving our predictive capacity on metastasis and survival [2, 5, 14, 34] in almost one quarter of breast carcinomas.
Conclusions: EMA staining patterns were very diverse and related to the histological types of cancer, although the result was not statistically significant. However, EMA staining patterns were significantly related to the histological grade of cancer, ER and PR positivity, and showed the capacity for predicting the nodal stage of dissemination of breast cancers. Thus, taking into account the previously demonstrated correlation of EMA with survival, EMA might be considered a differentiation tumor marker and a histological prognostic agent.
